Gallium-inducible transferrin-independent iron acquisition is a property of many cell types: Possible role of alterations in the plasma membrane

Journal of Investigative Medicine

Volumn 53, Issue 3, 2005, Pages 143-153

  Olakanmi, Oyebode ^a,b   Stokes, John B ^a,b,d   Britigan, Bradley E ^a,b,c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Gallium; Iron; Transport

Indexed keywords

CARBOHYDRATE; GALLIUM; LIPOSOME; MEMBRANE PROTEIN; NITRILOTRIACETIC ACID; PHOSPHOLIPID; TRANSFERRIN;

ARTICLE; CELL KINETICS; CELL MEMBRANE; CELL MEMBRANE FLUIDITY; CELL MEMBRANE POTENTIAL; CELL TYPE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ERYTHROCYTE; ERYTHROCYTE GHOST; FATTY ACID ANALYSIS; HUMAN; HUMAN CELL; IRON TRANSPORT;

EID: 18944394018     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2005.00310     Document Type: Article

References (29)

1. Miller RA, Britigan BE. The formation and biologic significance of phagocyte-derived oxidants. J Invest Med 1995;43:39-49.
2. Ponka P. Cellular iron metabolism. Kidney Int 1999;55 (Suppl):2-11.
3. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metals in human disease: an overview. Methods Enzymol 1990;186:1-85.
4. Thompson AB, Bohling T, Heires A, et al. Lower respiratory tract iron burden is increased in association with cigarette smoking. J Lab Clin Med 1991;117:493-9.
5. Olakanmi O, Stokes JB, Britigan BE. Acquisition of iron bound to low molecular weight chelates by human monocyte-derived macrophages. J Immunol 1994;153:2691-703.
6. Olakanmi O, Stokes JB, Pathan S, Britigan BE. Polyvalent cationic metals induce the rate of transferrin-independent iron acquisition by HL-60 cells. J Biol Chem 1997;272:2599-606.
7. Richardson D, Baker E. Two mechanisms of iron uptake from transferrin by melanoma cells. The effect of desferrioxamine and ferric ammonium citrate. J Biol Chem 1992;267:13972-9.
8. Richardson DR, Ponka P. Identification of a mechanism of iron uptake by cells which is stimulated by hydroxyl radicals generated via the iron-catalysed Haber-Weiss reaction. Biochim Biophys Acta 1995;1269:105-14.
9. Richardson DR. Iron and gallium increase iron uptake from transferrin by human melanoma cells: further examination of the ferric ammonium citrate-activated iron uptake process. Biochim Biophys Acta Mol Basis Dis 2001;1536:43-54.
10. Musílkova J, Kriegerbeckova K, Krusek J, Kovar J. Specific binding to plasma membrane is the first step in the uptake of non-transferrin iron by cultured cells. Biochim Biophys Acta 1998;1369:103-8.
11. Richardson DR, Baker E. The uptake of iron and transferrin by the human malignant melanoma cell. Biochim Biophys Acta 1990;1053:1-12.
12. Sturrock A, Alexander J, Lamb J, et al. Characterization of a transferrin-independent uptake system for iron in HeLa cells. J Biol Chem 1990;265:3139-45.
13. Basset P, Quesneau Y, Zwiller J. Iron-induced L1210 cell growth: evidence of a transferrin-independent iron transport. Cancer Res 1986;46:1644-7.
14. Chitambar CR, Sax D. Regulatory effects of gallium on transferrin-independent iron uptake by human leukemic HL60 cells. Blood 1992;80:505-11.
15. Bernstein LR. Mechanisms of therapeutic activity for gallium. Pharmacol Rev 1998;50:665-82.
16. Denicola A, Souza JM, Radi R, Lissi E. Nitric oxide diffusion in membranes determined by fluorescence quenching. Arch Biochem Biophys 1996;328:208-12.
17. Whitin JC, Chapman CE, Simons ER, et al. Correlation between membrane potential changes and superoxide production in human granulocytes stimulated by phorbol myristate acetate. Evidence for detective activation in chronic granulomatous disease. J Biol Chem 1980;255:1874-8.
18. Britigan BE, Hamill DR. Effect of the spin trap 5,5-dimethyl-1-pyrroline- N-oxide on human neutrophil function: novel inhibition of neutrophil stimulus-response coupling? Free Radic Biol Med 1990;8:459-70.
19. Nathan I, Ben-Valid I, Henzel R et al. Alterations in membrane lipid dynamics of leukemic cells undergoing growth arrest and differentiation: dependency on the inducing agent. Exp Cell Res 1998;239:442-6.
20. Seligman PA, Moran PL, Schleicher RB, Crawford ED. Treatment with gallium nitrate: evidence for interference with iron metabolism in vivo. Am J Hematol 1992;41:232-40.
21. Todd PA, Fitton A. Gallium nitrate. A review of its pharmacological properties and therapeutic potential in cancer-related hypercalcaemia. Drugs 1991;42:261-73.
22. Kelsen DP, Alcock N, Yeh S, et al. Pharmacokinetics of gallium nitrate in man. Cancer 1980;46:2009-13.
23. Wagner BA, Buettner GR, Burns CP. Free radical-mediated lipid peroxidation in cells: oxidizability is a function of cell lipid bis-allylic hydrogen content. Biochemistry 1994;33:4449-53.
24. Zha X, Pierini LM, Leopold PL, et al. Sphingomyelinase treatment induces ATP-independent endocytosis. J Cell Biol 1998;140:39-47.
25. 558 does not mediate iron uptake by myeloid cells. J Lab Clin Med 1999;134:275-82.
26. Britigan BE, Rasmussen GT, Olakanmi O, Cox CD. Iron acquisition from Pseudomonas aeruginosa siderophores by human phagocytes: an additional mechanism of host defense through iron sequestration? Infect Immun 2000;68:1271-5.
27. Scheiber-Mojdehkar B, Zimmermann I, Dresow B, Goldenberg H. Differential response of non-transferrin bound iron uptake in rat liver cells on long-term and short-term treatment with iron. J Hepatol 1999;31:61-70.
28. Chitambar CR, Massey EJ, Seligman PA. Regulation of transferrin receptor expression on human leukemic cells during proliferation and induction of differentiation. Effects of gallium and dimethylsulfoxide. J Clin Invest 1983;72:1314-25.
29. Olakanmi O, Rasmussen GT, Lewis TS, et al. Multivalent metal-induced iron acquisition from transferrin and lactoferrin by myeloid cells. J Immunol 2002;169:2076-84.